Dyne Therapeutics INC
-$85.0M
Net Activity
Institutions Holding
227
Popularity Rank
#2589
Avg Weight
0.38%
Total Value
$3.4B
227 institutions currently hold DYN, with 134 net buyers and 108 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
108
Net Buying Institutions
134
Top 5 by Value
+$1.9B
Total Buy Value
$1.4B
Total Sell Value
134
Net Buyers
108
Net Sellers
25
Filings (90d)
$40.33M
Total Est. Value
1.90M shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Atlas Venture Fund XI, LP | 2026-07-07 | $3.52M |
| ATLAS VENTURE ASSOCIATES XI, L.P. | 2026-07-07 | $114K |
| Atlas Venture Opportunity Fund II, LP | 2026-07-07 | $1.77M |
| Atlas Venture Opportunity Fund I, LP | 2026-07-07 | $1.39M |
| Atlas Venture Fund XI, LP | 2026-07-06 | $5.84M |
| Atlas Venture Opportunity Fund I, LP | 2026-07-06 | $2.31M |
| Atlas Venture Opportunity Fund II, LP | 2026-07-06 | $2.93M |
| Atlas Venture Opportunity Fund II, L.P. | 2026-06-29 | $1.08M |
| Atlas Venture Opportunity Fund I, L.P. | 2026-06-29 | $852K |
| Atlas Venture Fund XI, L.P. | 2026-06-29 | $2.16M |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
No Form 8-K filings for this ticker
The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter